<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(12)</volume><submitter>Terada K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Successful restoration of epicardial coronary artery patency by primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) does not always lead to adequate reperfusion at the microvascular level.&lt;h4>Aims&lt;/h4>This study sought to investigate the association between lipid-rich coronary plaque identified by near-infrared spectroscopy combined with intravascular ultrasound (NIRS-IVUS) and microvascular obstruction (MVO) detected by cardiac magnetic resonance imaging (MRI) after PPCI for STEMI.&lt;h4>Methods&lt;/h4>We investigated 120 patients with STEMI undergoing PPCI. NIRS-IVUS was used to measure the maximum lipid core burden index in 4 mm (maxLCBI4 mm) in the infarct-related lesions before PPCI. Delayed contrast-enhanced cardiac MRI was performed to evaluate MVO one week after PPCI.&lt;h4>Results&lt;/h4>MVO was identified in 40 (33%) patients. MaxLCBI4 mm in the infarct-related lesion was significantly larger in the MVO group compared with the no-MVO group (median [interquartile range]: 745 [522-853] vs 515 [349-698], p&lt;0.001). A multivariable logistic regression model showed that maxLCBI4 mm was an independent predictor of MVO (odds ratio: 24.7 [95% confidence interval: 2.5-248.0], p=0.006). Receiver operating characteristic curve analysis demonstrated that maxLCBI4 mm >600 was the optimal cut-off value to predict MVO (Youden index=0.44 and area under the curve=0.71) with a sensitivity of 75% and a specificity of 69%.&lt;h4>Conclusions&lt;/h4>Lipid content measured by NIRS in the infarct-related lesions was associated with the occurrence of MVO after PPCI in STEMI.</pubmed_abstract><journal>EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology</journal><pagination>e999-e1006</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9724955</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Near-infrared spectroscopy to predict microvascular obstruction after primary percutaneous coronary intervention.</pubmed_title><pmcid>PMC9724955</pmcid><pubmed_authors>Wada T</pubmed_authors><pubmed_authors>Terada K</pubmed_authors><pubmed_authors>Madder RD</pubmed_authors><pubmed_authors>Akasaka T</pubmed_authors><pubmed_authors>Takahata M</pubmed_authors><pubmed_authors>Kubo T</pubmed_authors><pubmed_authors>Shiono Y</pubmed_authors><pubmed_authors>Nishi T</pubmed_authors><pubmed_authors>Higashioka D</pubmed_authors><pubmed_authors>Emori H</pubmed_authors><pubmed_authors>Khalifa AKM</pubmed_authors><pubmed_authors>Shimamura K</pubmed_authors><pubmed_authors>Ino Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Near-infrared spectroscopy to predict microvascular obstruction after primary percutaneous coronary intervention.</name><description>&lt;h4>Background&lt;/h4>Successful restoration of epicardial coronary artery patency by primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) does not always lead to adequate reperfusion at the microvascular level.&lt;h4>Aims&lt;/h4>This study sought to investigate the association between lipid-rich coronary plaque identified by near-infrared spectroscopy combined with intravascular ultrasound (NIRS-IVUS) and microvascular obstruction (MVO) detected by cardiac magnetic resonance imaging (MRI) after PPCI for STEMI.&lt;h4>Methods&lt;/h4>We investigated 120 patients with STEMI undergoing PPCI. NIRS-IVUS was used to measure the maximum lipid core burden index in 4 mm (maxLCBI4 mm) in the infarct-related lesions before PPCI. Delayed contrast-enhanced cardiac MRI was performed to evaluate MVO one week after PPCI.&lt;h4>Results&lt;/h4>MVO was identified in 40 (33%) patients. MaxLCBI4 mm in the infarct-related lesion was significantly larger in the MVO group compared with the no-MVO group (median [interquartile range]: 745 [522-853] vs 515 [349-698], p&lt;0.001). A multivariable logistic regression model showed that maxLCBI4 mm was an independent predictor of MVO (odds ratio: 24.7 [95% confidence interval: 2.5-248.0], p=0.006). Receiver operating characteristic curve analysis demonstrated that maxLCBI4 mm >600 was the optimal cut-off value to predict MVO (Youden index=0.44 and area under the curve=0.71) with a sensitivity of 75% and a specificity of 69%.&lt;h4>Conclusions&lt;/h4>Lipid content measured by NIRS in the infarct-related lesions was associated with the occurrence of MVO after PPCI in STEMI.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-05T11:32:17.632Z</modification><creation>2025-04-05T11:32:17.632Z</creation></dates><accession>S-EPMC9724955</accession><cross_references><pubmed>34105512</pubmed><doi>10.4244/EIJ-D-20-01421</doi><doi>10.4244/eij-d-20-01421</doi></cross_references></HashMap>